Survival Outcomes in Breast Cancer Patients With Metastatic Bone Disease
These findings suggest that patients with bone-only metastases, particularly those with solitary lesions, exhibit significantly longer survival. Although systemic therapy remains the standard these findings suggest that patients with bone-only metastases, particularly those with solitary lesions, exhibit significantly longer survival. Although systemic therapy remains the standard, these findings highlight the need for further research into whether selected patients may benefit from integrating local treatment approaches, including surgery, into their management.
Authors
- Colm Power (ORCID: https://orcid.org/0000-0001-6792-6754)
- Leonie S. Young (ORCID: https://orcid.org/0000-0002-4904-0367)
- Arnold D. K. Hill (ORCID: https://orcid.org/0000-0001-9617-7983)
- Trudi Roche
- Aisling Hegarty (ORCID: https://orcid.org/0000-0002-4514-3334)
- Sandra Hembrecht (ORCID: https://orcid.org/0000-0001-5774-4500)
- Michael Allen
- Nuala Healy (ORCID: https://orcid.org/0000-0002-0620-6056)
- Gavin P Dowling (ORCID: https://orcid.org/0000-0002-2267-2022)
- Gerard Hill
- Gordon Daly
- Eithne Downey
Institutions
- Beaumont Hospital (IE)
Publication Details
- Journal
- World Journal of Surgery
- Published
- 2025-10-28
- DOI
- https://doi.org/10.1002/wjs.70147
- Primary Topic
- Management of metastatic bone disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00